The Spine Journal published the study.
Here are five highlights:
1. The researchers concluded PEMF therapy may decrease cellular inflammation and degeneration connected with disc degeneration in IVD cells.
2. The study’s results provide insight into PEMF having disease modifying activities that could offer a minimally-invasive solution for patients with degenerative disc disease.
3. Jeffrey C. Lotz, PhD, of University of California, San Francisco, and his team stimulated cells to create the inflammatory environment associated with degenerative disc disease. The cells underwent the Orthofix Physio-Stim PEMF for four hours every day.
4. Those cells exposed to PEMF demonstrated a decrease in pro-inflammatory marker, compared to the control group.
5. The FDA has approved the Orthofix Physio-Stim and Cervical-Stim PEMF technology.
More articles on devices:
Globus Medical 2015 net income hits $112.8M: 6 things to know
Neurosurgery device developer addresses market demand for new brain technologies: 6 notes
CoNextions Medical to introduce tendon repair device at AAOS meeting: 3 quick notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
